Page last updated: 2024-08-25

rosiglitazone and Cirrhoses, Experimental Liver

rosiglitazone has been researched along with Cirrhoses, Experimental Liver in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (50.00)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bennett, RG; Hamel, FG; Simpson, RL1
Chen, SZ; Li, JJ; Li, YY; Yu, FX; Zheng, YH; Zhi, SC1
Aeed, H; Bruck, R; Halpern, Z; Pines, M; Weiss, S; Zvibel, I1
Han, F; Kong, LB; Nan, YM; Wang, RQ; Wu, WJ; Yu, J; Zhao, SX1
Kher, G; Misra, A; Patel, G1
Antonelli, E; Fiorucci, S; Mencarelli, A; Morelli, A; Pellicciari, R; Pruzanski, M; Renga, B; Riccardi, L; Rizzo, G1
Awada, M; Bautista, A; Gardner, JL; Hellerstein, MK; Lindwall, G; Turner, SM1
Anania, FA; Miyahara, T; Motomura, K; Rippe, R; Schrum, L; Tsukamoto, H; Willson, TM; Xiong, S; Yee, HF1

Other Studies

8 other study(ies) available for rosiglitazone and Cirrhoses, Experimental Liver

ArticleYear
Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis.
    World journal of gastroenterology, 2017, Jun-14, Volume: 23, Issue:22

    Topics: Actins; Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Collagen Type I; Drug Therapy, Combination; Hepatic Stellate Cells; Liver; Liver Cirrhosis, Experimental; Male; Mice, Inbred C57BL; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Recombinant Proteins; Relaxin; Rosiglitazone; Thiazolidinediones

2017
Rosiglitazone Inhibits Activation of Hepatic Stellate Cells via Up-Regulating Micro-RNA-124-3p to Alleviate Hepatic Fibrosis.
    Digestive diseases and sciences, 2019, Volume: 64, Issue:6

    Topics: Animals; Carbon Tetrachloride; Cells, Cultured; Chemical and Drug Induced Liver Injury; Collagen Type I; Collagen Type I, alpha 1 Chain; Hepatic Stellate Cells; Liver; Liver Cirrhosis, Experimental; Male; Mice, Inbred BALB C; MicroRNAs; PPAR gamma; RNA, Long Noncoding; Rosiglitazone; Signal Transduction; Up-Regulation

2019
Additive inhibitory effect of experimentally induced hepatic cirrhosis by agonists of peroxisome proliferator activator receptor gamma and retinoic acid receptor.
    Digestive diseases and sciences, 2009, Volume: 54, Issue:2

    Topics: Alitretinoin; Animals; Cell Proliferation; Collagen Type I; Cytokines; Drug Synergism; Hepatic Stellate Cells; Liver Cirrhosis, Experimental; Male; PPAR gamma; Prostaglandin D2; Proto-Oncogene Proteins c-jun; Rats; Rats, Wistar; Retinoid X Receptors; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Thioacetamide; Tretinoin

2009
Adenovirus-mediated peroxisome proliferator activated receptor gamma overexpression prevents nutritional fibrotic steatohepatitis in mice.
    Scandinavian journal of gastroenterology, 2011, Volume: 46, Issue:3

    Topics: Adenoviridae; Anilides; Animals; beta-Galactosidase; Choline; Diet; Fatty Liver; Genetic Vectors; Inflammation; Liver Cirrhosis; Liver Cirrhosis, Experimental; Male; Methionine; Mice; Mice, Inbred C57BL; PPAR gamma; Random Allocation; Rosiglitazone; Thiazolidinediones; Transfection

2011
Preparation and evaluation of hepatic stellate cell selective, surface conjugated, peroxisome proliferator-activated receptor-gamma ligand loaded liposomes.
    Journal of drug targeting, 2012, Volume: 20, Issue:2

    Topics: Albumins; Animals; Biological Availability; Biomarkers; Carbon Tetrachloride; Drug Delivery Systems; Hepatic Stellate Cells; Humans; Injections, Intravenous; Liposomes; Liver; Liver Cirrhosis, Experimental; Male; Mannosephosphates; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones

2012
Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 315, Issue:1

    Topics: Animals; Cells, Cultured; Chenodeoxycholic Acid; DNA-Binding Proteins; Gene Expression Regulation; Humans; Liver; Liver Cirrhosis, Experimental; PPAR gamma; Rats; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Transcription Factors

2005
Measurement of liver collagen synthesis by heavy water labeling: effects of profibrotic toxicants and antifibrotic interventions.
    American journal of physiology. Gastrointestinal and liver physiology, 2007, Volume: 292, Issue:6

    Topics: Administration, Oral; Alanine; Animals; Atorvastatin; Carbon Tetrachloride; Collagen; Deuterium Oxide; Drug Evaluation, Preclinical; Enalapril; Gas Chromatography-Mass Spectrometry; Griseofulvin; Heptanoic Acids; Hydroxyproline; Interferon-gamma; Liver; Liver Cirrhosis, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Pyrroles; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Rosiglitazone; Species Specificity; Thiazolidinediones; Time Factors

2007
Peroxisome proliferator-activated receptors and hepatic stellate cell activation.
    The Journal of biological chemistry, 2000, Nov-17, Volume: 275, Issue:46

    Topics: Animals; Cell Size; Cell Survival; Cells, Cultured; Collagen; DNA; Gene Expression Regulation; Liver; Liver Cirrhosis, Biliary; Liver Cirrhosis, Experimental; Male; Promoter Regions, Genetic; Prostaglandin D2; Protein Binding; Protein Isoforms; Pyrimidines; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Tumor Necrosis Factor-alpha

2000